(Q46947976)

26 December 2017

title

Current issues and trends in the diagnosis and treatment of adults with ADHD. (English)

1 reference

26 December 2017

4

Lily Hechtman

1 reference

26 December 2017

author name string

Lucy Cumyn

series ordinal

1

1 reference

26 December 2017

Dusan Kolar

series ordinal

2

1 reference

26 December 2017

Amanda Keller

series ordinal

3

1 reference

26 December 2017

publication date

1 October 2007

1 reference

26 December 2017

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

26 December 2017

volume

7

1 reference

26 December 2017

issue

10

1 reference

26 December 2017

page(s)

1375-1390

1 reference

26 December 2017

Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

What is the prevalence of adult ADHD? Results of a population screen of 966 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Psychosocial treatments for ADHD in teens and adults: a practice-friendly review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Diagnostic issues for adolescents and adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

The effect of ADHD on the life of an individual, their family, and community from preschool to adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Molecular genetics of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Attention-Deficit Hyperactivity Disorder in the post-genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Investigation of parent-of-origin effects in ADHD candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Attention-deficit/hyperactivity disorder pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

The neuropsychopharmacology of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Structural brain imaging of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Brain function and structure in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Attention-deficit/hyperactivity disorder: a selective overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Smoking during pregnancy and the risk for hyperkinetic disorder in offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Prenatal smoking exposure, low birth weight, and disruptive behavior disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Impact of low birth weight on attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Family adversity in DSM-IV ADHD combined and inattentive subtypes and associated disruptive behavior problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Retrospective reports of childhood trauma in adults with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Clinical assessment and treatment of attention deficit hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Stimulants: Therapeutic actions in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Attention deficit/hyperactivity disorder across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Methyiphenidate vs. amphetamine: Comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

ADHD: new pharmacological treatments on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A Systematic Review of Modafinil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A review of the use of modafinil for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Use of modafinil for the treatment of attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A conceptual model of child psychopathology: implications for understanding attention deficit hyperactivity disorder and treatment efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

A combined treatment approach for adults with ADHD--results of an open study of 43 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

The marital and family functioning of adults with ADHD and their spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Atomoxetine and Adult Attention-Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: Issues of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

Does multimodal treatment of ADHD decrease other diagnoses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.10.1375

10.1586/14737175.7.10.1375

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017